Sandbox:iqra

Revision as of 16:14, 2 October 2017 by Usama Talib (talk | contribs)
Jump to navigation Jump to search
 
 
 
 
 
 
 
High probability
(>5%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Duodenal biopsy
• TTGA IgG
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Both negative
 
 
 
Both positive
 
 
 
Serology/biopsy disagreement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Celiac disease unlikely
 
 
 
Celiac disease
 
 
 
Needs
• HLA DQ2 and DQ8 genotyping
•IgA level ± TTGA/DGP IgG
•work up for other causes of villous atrophy


Celiac disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Celiac disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modifications
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox:iqra On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox:iqra

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox:iqra

CDC on Sandbox:iqra

Sandbox:iqra in the news

Blogs onSandbox:iqra

Directions to Hospitals Treating Celiac disease

Risk calculators and risk factors for Sandbox:iqra

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: : Iqra Qamar M.D.[2]

Overview

Laboratory Findings

Electrolyte and Biomarker Studies

  • Complete blood count (CBC)
  • Liver function tests (LFTs)
  • B12
  • Vitamin D
  • Folate
  • Ferritin (+/- Ca, alk phos) – at diagnosis and annually

Serologic Markers

Serologic tests may be divided into 2 groups based upon antibodies against respective antigens:

  1. anti-TTG Ab tests
  2. anti-gliadin antibody tests 
  • IgA endomysial antibody (IgA EMA)
  • IgA tissue transglutaminase antibody (IgA tTG)
  • IgG tissue transglutaminase antibody (IgG tTG)
  • IgA deamidated gliadin peptide (IgA DGP)
  • IgG deamidated gliadin peptide (IgG DGP)

IgA endomysial assay:

  • Endomysial antibodies bind to the endomysium and can be seen via indirect immunofluorescence producing a staining pattern. The target antigen is a tissue transglutaminase
  • IgA EMA have high specificity and even low titres indicate a positive test result
  • It has moderate sensitivity but high specificity for untreated celiac disease and is negative in treated patients.

Anti-tissue transglutaminase antibodies:

  • These antibodies are directed against tissue transglutaminase-2 (tTG) antigen.
  • They can be easily detected by ELISA
  • Anti-tTG antibodies have high diagnostic accuracy

Antigliadin antibody assays:

NOTE:

  • Serum IgA EMA and IgA tTG have the highest diagnostic accuracy
  • The IgA and IgG antigliadin antibody (AGA) are not recommended for estabilishing diagnosis as they have low accuracy and give more false positive results when compared with IgA tTG and IgA DGP assays
  • The anti-deamidated gliadin peptide (DGP) assays also have high diagnostic accuracy

Sensitivity and Specificity of Antibody testing:

Literature review has shown that IgA endomysial and IgA tissue transglutaminase antibodies have a sensitivity more than 95% and a specificity almost 100%. However variations in results are seen among different laboratories.

Blood antibody tests for coeliac disease
Test sensitivity specificity
IgA enomysial antibody 85 to 98% 97 to 100%
IgA tissue transglutaminase antibody 90 to 98% 95 to 97%
IgA deamidated gliadin peptide 94% 99%
IgG deamidated gliadin peptide 92% 100%
Blood HLA tests for coeliac disease
Test sensitivity specificity
HLA-DQ2 94% 73%
HLA-DQ8 12% 81%

Cerberal Palsy

https://https://www.youtube.com/watch?v=csKRVW-HN0E%7C350}}

WikiDoc Resources for Sandbox:iqra

Articles

Most recent articles on Sandbox:iqra

Most cited articles on Sandbox:iqra

Review articles on Sandbox:iqra

Articles on Sandbox:iqra in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sandbox:iqra

Images of Sandbox:iqra

Photos of Sandbox:iqra

Podcasts & MP3s on Sandbox:iqra

Videos on Sandbox:iqra

Evidence Based Medicine

Cochrane Collaboration on Sandbox:iqra

Bandolier on Sandbox:iqra

TRIP on Sandbox:iqra

Clinical Trials

Ongoing Trials on Sandbox:iqra at Clinical Trials.gov

Trial results on Sandbox:iqra

Clinical Trials on Sandbox:iqra at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sandbox:iqra

NICE Guidance on Sandbox:iqra

NHS PRODIGY Guidance

FDA on Sandbox:iqra

CDC on Sandbox:iqra

Books

Books on Sandbox:iqra

News

Sandbox:iqra in the news

Be alerted to news on Sandbox:iqra

News trends on Sandbox:iqra

Commentary

Blogs on Sandbox:iqra

Definitions

Definitions of Sandbox:iqra

Patient Resources / Community

Patient resources on Sandbox:iqra

Discussion groups on Sandbox:iqra

Patient Handouts on Sandbox:iqra

Directions to Hospitals Treating Sandbox:iqra

Risk calculators and risk factors for Sandbox:iqra

Healthcare Provider Resources

Symptoms of Sandbox:iqra

Causes & Risk Factors for Sandbox:iqra

Diagnostic studies for Sandbox:iqra

Treatment of Sandbox:iqra

Continuing Medical Education (CME)

CME Programs on Sandbox:iqra

International

Sandbox:iqra en Espanol

Sandbox:iqra en Francais

Business

Sandbox:iqra in the Marketplace

Patents on Sandbox:iqra

Experimental / Informatics

List of terms related to Sandbox:iqra

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief:

For patient information, click here

Sandbox:iqra
The motor tract.
ICD-10 G80
ICD-9 343
OMIM 603513 605388
DiseasesDB 2232
MeSH D002547

Overview

Cerebral palsy (CP) is an umbrella term encompassing a group of non-progressive,[1] non-contagious diseases that cause physical disability in human development.

The incidence in developed countries is approximately 2.12–2.45 per 1000 live births.[2] Incidence has not declined over the last 60 years despite medical advances (such as electro-fetal monitoring) because these advances allow extremely low birth weight and premature babies to survive. Cerebral refers to the affected area of the brain, the cerebrum (however the centres have not been perfectly localised and the disease most likely involves connections between the cortex and other parts of the brain such as the cerebellum) and palsy refers to disorder of movement. CP is caused by damage to the motor control centers of the young developing brain and can occur during pregnancy (about 75 percent), during childbirth (about 5 percent) or after birth (about 15 percent) up to about age three. Eighty percent of causes are unknown; for the small number where cause is known this can include infection, malnutrition, and/or head trauma in very early childhood.[citation needed]

It is a non-progressive disorder, meaning the brain damage does not worsen, but secondary orthopedic deformities are common. There is no known cure for CP. Medical intervention is limited to the treatment and prevention of complications possible from CP's consequences.

CP is the second-most expensive developmental disability to manage over the course of a person's lifetime (second to mental retardation), with an average lifetime cost per person of USD$921,000 (in 2003 dollars).[3]

Onset of arthritis and osteoporosis can occur much sooner in adults with CP. Further research is needed on adults with CP, as the current literature body is highly focused on the pediatric patient. CP's resultant motor disorder(s) are sometimes, though not always, accompanied by "disturbances of sensation, cognition, communication, perception, and/or behavior, and/or by a seizure disorder”.[4][5]

Historical Perspective

CP, then known as "Cerebral Paralysis", was first identified by English surgeon William Little in 1860. Little raised the possibility of asphyxia during birth as a chief cause of the disorder. It was not until 1897 that Sigmund Freud, then a neurologist, suggested that a difficult birth was not the cause but rather only a symptom of other effects on fetal development.[6] Research conducted during the 1980s by the National Institute of Neurological Disorders and Stroke (NINDS) suggested that only a small number of cases of CP are caused by lack of oxygen during birth.[7]

Cultural aspects

Use of terms when referring to people with CP

People would rather be referred to as a person with a disability instead of handicapped. "Cerebral Palsy: A Guide for Care" at the University of Delaware offers the following guidelines:[8]

Impairment is the correct term to use to define a deviation from normal, such as not being able to make a muscle move or not being able to control an unwanted movement. Disability is the term used to define a restriction in the ability to perform a normal activity of daily living which someone of the same age is able to perform. For example, a three year old child who is not able to walk has a disability because normal three year old can walk independently. Handicap is the term used to describe a child or adult who, because of the disability, is unable to achieve the normal role in society commensurate with his age and socio-cultural milieu. As an example, a sixteen-year- old who is unable to prepare his own meal or care for his own toileting or hygiene needs is handicapped. On the other hand, a sixteen-year- old who can walk only with the assistance of crutches but who attends a regular school and is fully independent in activities of daily living is disabled but not handicapped. All disabled people are impaired, and all handicapped people are disabled, but a person can be impaired and not necessarily be disabled, and a person can be disabled without being handicapped.

The term "spastic" describes the attribute of spasticity in types of spastic CP. In 1952 a UK charity called The Spastics Society was formed.[9] The term "spastics" was used by the charity as a term for people with CP. The word "spaz" has since been used extensively as a general insult to disabled people, which some see as extremely offensive. It is also frequently used to insult able-bodied people when they seem overly anxious or unskilled in sports. The charity changed its name to Scope in 1994.[9] In the United States the word spaz has the same usage as an insult, but is not generally associated with CP.[10]

Misconceptions

A common misconception about those born with Cerebral Palsy is that they are less intelligent than those born without it. Cerebral Palsy is defined as damage to the part of the brain that controls movement; areas of the brain which define a persons intelligence are not affected by CP.

Spastic Cerebral Palsy, the most common form of CP, causes the muscles to be tense, rigid and movements are slow and difficult. This can be misinterpreted as cognitive delay due to difficulty of communication. Individuals with cerebral palsy can have learning difficulties, but sometimes it is the sheer magnitude of problems caused by the underlying brain injury, which prevents the individual from expressing what cognitive abilities they do possess. [4]

Public perception

Those with CP are sometimes stigmatized and shunned. This has lessened since the 1950s thanks to public education and to United Cerebral Palsy in the U.S. and similar organizations in other countries. Prior to that time the great majority were often sent to asylums or confined to attics. They were perceived to be the products of incest and partial smotherings.[citation needed] Often parents kept their children away from them in the mistaken belief that the condition was the product of disease or poor sanitary habits.

Thomas Galton believed that there was a correlation between physical disability and aptitude, and this attitude remained prevalent as concerned CP until the 1970s. At this time, CP was an overdiagnosed disorder, and a common misunderstanding then and now is that CP causes mental retardation. In fact, only CP individuals with brain damage in the hippocampus or the frontal cerebral cortex develop mental retardation. While learning difficulties and CP may co-occur, it is common for individuals with CP to lead normal lives.

Classification

CP is divided into four major classifications to describe the different movement impairments. These classifications reflect the area of brain damaged. The four major classifications are:

  • Spastic
  • Athetoid/Dyskinetic
  • Ataxic
  • Mixed

In 30 percent of all cases of CP, the spastic form is found along with one of the other types. There are a number of other, less prevalent types of CP, but these are the most common.

A general classification is as follows:

Spastic

Spastic (ICD-10 G80.0-G80.1) cerebral palsy is by far the most common type, occurring in 70% to 80% of all cases. People with this type are hypertonic and have a neuromuscular condition stemming from damage to the corticospinal tract, motor cortex, or pyramidal tract that affects the nervous system's ability to receive gamma amino butyric acid in the area(s) affected by the spasticity. Spastic CP is further classified by topography dependent on the region of the body affected; these include:

  • spastic hemiplegia (one side being affected). Generally, injury to the left side of the brain will cause a right hemiplegia and injury to the right side a left hemiplegia. Childhood hemiplegia is a relatively common condition, affecting up to one child in 1,000.
  • spastic diplegia (whole body affected, but the lower extremities affected more than the upper extremities). Most people with spastic diplegia do eventually walk. The gait of a person with spastic diplegia is typically characterized by a crouched gait. Toe walking and flexed knees are common. Hip problems, dislocations, and side effects like strabismus (crossed eyes) are common. Strabismus affects three quarters of people with spastic diplegia. This is due to weakness of the muscles that control eye movement. In addition, these individuals are often nearsighted. In many cases the IQ of a person with spastic diplegia is normal.
  • spastic quadriplegia (Whole body affected; all four limbs affected equally). Some children with quadriplegia also suffer from hemiparetic tremors; an uncontrollable shaking that affects the limbs on one side of the body and impairs normal movement. A common problem with children suffering from quadriplegia is fluid buildup. Diuretics and steroids are medications administered to decrease any buildup of fluid in the spine that is caused by leakage from dead cells. Hardened feces in a quadriplegia patient are important to monitor because it can cause high blood pressure. Autonomic dysreflexia can be caused by hardened feces, urinary infections, and other problems, resulting in the overreaction of the nervous system and can result in high blood pressure, heart attacks, and strokes. Blockage of tubes inserted into the body to drain or enter fluids also needs to be monitored to prevent autonomic dysreflexia in quadriplegia. The proper functioning of the digestive system needs to be monitored as well.

Occasionally, terms such as monoplegia, paraplegia, triplegia, and pentaplegia may also be used to refer to specific manifestations of the spasticity.

Ataxic

Ataxia (ICD-10 G80.4) type symptoms can be caused by damage to the cerebellum. Forms of ataxia, such as Bruns' Frontal Ataxia, and Friedreich's Ataxia are less common types of Cerebral Palsy, occurring in at most 10% of all cases. Some of these individuals have hypotonia and tremors. Motor skills like writing, typing, or using scissors might be difficult, as well as problems with balance, especially while walking. It is common for individuals to have difficulty with visual and/or auditory processing of objects.

Athetoid/dyskinetic

Athetoid or dyskinetic (ICD-10 G80.3) is mixed muscle tone - sometimes hypertonia and sometimes hypotonia. People with athetoid CP have trouble holding themselves in an upright, steady position for sitting or walking, and often show involuntary motions. For some people with athetoid CP, it takes a lot of work and concentration to get their hand to a certain spot (like scratching their nose or reaching for a cup). Because of their mixed tone and trouble keeping a position, they may not be able to hold onto objects (such as a toothbrush or pencil). About one-fourth of all people with CP have athetoid CP. The damage occurs to the extrapyramidal motor system and/or pyramidal tract and to the basal ganglia. It occurs in 40% of all cases.

Pathophysiology

Presentation: bones

In order for bones to attain their normal shape and size, they require the stresses from normal musculature. Osseous findings will therefore mirror the specific muscular deficits in a given person with CP. The shafts of the bones are often thin (gracile). When compared to these thin shafts (diaphyses) the metaphyses often appear quite enlarged (ballooning). With lack of use, articular cartilage may atrophy, leading to narrowed joint spaces. Depending on the degree of spasticity, a person with CP may exhibit a variety of angular joint deformities. Because vertebral bodies need vertical gravitational loading forces to develop properly, spasticity and an abnormal gait can hinder proper and/or full bone and skeletal development. People with CP tend to be shorter in height than the average person because their bones are not allowed to grow to their full potential. Sometimes bones grow at different lengths, so the person may have one leg longer than the other.

Causes

Doctors aren't sure what causes CP. This matter has been debated over the years with no obvious answers or conclusions.

Some causes of CP are asphyxia, hypoxia of the brain, birth trauma, premature birth, and certain infections in the mother during and before birth such as strep infections, central nervous system infections, trauma, consecutive hematomas, and placenta abruptio.

Between 40% and 50% of all children who develop cerebral palsy were born prematurely. Premature babies have a higher risk in part because their organs are not yet fully developed. This increases the risk of asphyxia and other injury to the brain, which in turn increases the incidence of CP. Periventricular leukomalacia is an important cause of CP.

Recent research has demonstrated that intrapartum asphyxia is not the most important cause, probably accounting for no more than 10 percent of all cases; rather, infections in the mother, even infections that are not easily detected, may triple the risk of the child developing the disorder, mainly as the result of the toxicity to the fetal brain of cytokines that are produced as part of the inflammatory response.[11]

The risk of a baby having CP increases as the birth weight decreases. A baby who is born prematurely usually has a low birth weight, less than 5.5 lb, but full-term babies can also have low birth weights. Multiple-birth babies are more likely than single-birth babies to be born early or with a low birth weight.

After birth, the condition may be caused by toxins, severe jaundice, lead poisoning, physical brain injury, shaken baby syndrome, incidents involving hypoxia to the brain (such as near drowning), and encephalitis or meningitis. The three most common causes of asphyxia in the young child are: choking on foreign objects such as toys and pieces of food; poisoning; and near drowning.

Some structural brain anomalies such as lissencephaly cause symptoms of CP, although whether that could be considered CP is a matter of opinion (some people say CP must be due to brain damage, whereas these people never had a normal brain). Often this goes along with rare chromosome disorders and CP is not genetic or hereditary.

Differentiating Sandbox:iqra from Other Diseases

Epidemiology and Demographics

Incidence and prevalence

In the industrialized world, the incidence of cerebral palsy is about 2 per 1000 live births.[12] The incidence is higher in males than in females; the Surveillance of Cerebral Palsy in Europe (SCPE) reports a M:F ratio of 1.33:1.[13] Variances in reported rates of incidence across different geographical areas in industrialized countries are thought to be caused primarily by discrepancies in the criteria used for inclusion and exclusion. When such discrepancies are taken into account in comparing two or more registers of patients with cerebral palsy (for example, the extent to which children with mild cerebral palsy are included), the incidence rates converge toward the average rate of 2:1000.

In the United States, approximately 10,000 infants and babies are diagnosed with CP each year, and 1200-1500 are diagnosed at preschool age.[14]

Overall, advances in care of pregnant mothers and their babies has not resulted in a noticeable decrease in CP. This is generally attributed to medical advances in areas related to the care of premature babies (which results in a greater survival rate). Only the introduction of quality medical care to locations with less-than-adequate medical care has shown any decreases. The incidence of CP increases with premature or very low-weight babies regardless of the quality of care.[citation needed]

Prevalence of cerebral palsy is best calculated around the school entry age of about six years, the prevalence in the U.S. is estimated to be 2.4 out of 1000 children[15]

The SCPE reported the following incidence of comorbidities in children with CP (the data are from 1980-1990 and included over 4,500 children over age 4 whose CP was acquired during the prenatal or neonatal period):

  • Mental retardation (IQ < 50): 31%
  • Active seizures: 21%
  • Mental retardation (IQ < 50) and not walking: 20%
  • Blindness: 11%[16]

The SCPE noted that the incidence of comorbidities is difficult to measure accurately, particularly across centers. For example, the actual rate of mental retardation may be difficult to determine, as the physical and communicational limitations of people with CP would likely lower their scores on an IQ test if they were not given a correctly modified version.

Apgar scores have sometimes been used as one factor to predict whether or not an individual will develop CP.[17]

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

All types of CP are characterized by abnormal muscle tone, posture (i.e. slouching over while sitting), reflexes, or motor development and coordination. There can be joint and bone deformities and contractures (permanently fixed, tight muscles and joints). The classical symptoms are spasticity, spasms, other involuntary movements (e.g. facial gestures), unsteady gait, problems with balance, and/or soft tissue findings consisting largely of decreased muscle mass. Scissor walking (where the knees come in and cross) and toe walking are common among people with CP who are able to walk, but taken on the whole, CP symptomatology is very diverse. The effects of cerebral palsy fall on a continuum of motor dysfunction which may range from "clumsy" and awkward movements on one end of the spectrum to such severe impairments that coordinated movements are almost impossible on the other end of the spectrum.

Babies born with severe CP often have an irregular posture; their bodies may be either very floppy or very stiff. Birth defects, such as spinal curvature, a small jawbone, or a small head sometimes occur along with CP. Symptoms may appear, change, or become more severe as a child gets older. Some babies born with CP do not show obvious signs right away.

Secondary conditions can include seizures, epilepsy, speech or communication disorders, eating problems, sensory impairments, mental retardation, learning disabilities, and/or behavioral disorders.

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

There is no cure for CP, but various forms of therapy can help a person with the disorder to function and live more effectively. Many[citation needed] children go on to enjoy near-normal[citation needed] adult lives if their disabilities are properly managed. In general, the earlier treatment begins the better chance children have of overcoming developmental disabilities or learning new ways to accomplish the tasks that challenge them. Treatment may include one or more of the following: physical therapy; occupational therapy; speech therapy; drugs to control seizures, alleviate pain, or relax muscle spasms (e.g. benzodiazepienes, baclofen and intrathecal phenol/baclofen); hyperbaric oxygen; the use of Botox to relax contracting muscles; surgery to correct anatomical abnormalities or release tight muscles; braces and other orthotic devices; wheelchairs and rolling walkers; and communication aids such as computers with attached voice synthesizers. For instance the use of a standing frame can help reduce spasticity and improve range of motion for people with CP who use wheelchairs. Nevertheless, there is only some benefit from therapy. Treatment is usually symptomatic and focuses on helping the person to develop as many motor skills as possible or to learn how to compensate for the lack of them. Non-speaking people with CP are often successful availing themselves of augmentative and alternative communication systems such as Blissymbols.

Physical therapy (PT) programs are designed to encourage the patient to build a strength base for improved gait and volitional movement, together with stretching programs to limit contractures. Many experts believe that life-long physical therapy is crucial to maintain muscle tone, bone structure, and prevent dislocation of the joints.

Occupational therapy helps adults and children maximise their function, adapt to their limitations and live as independently as possible.[18][19]

Orthotic devices such as ankle-foot orthoses (AFOs) are often prescribed to minimize gait irregularities. AFOs have been found to improve several measures of ambulation, including reducing energy expenditure[20] and increasing speed and stride length.[21]

Speech therapy helps control the muscles of the mouth and jaw, and helps improve communication. Just as CP can affect the way a person moves their arms and legs, it can also affect the way they move their mouth, face and head. This can make it hard for the person to breathe; talk clearly; and bite, chew and swallow food. Speech therapy often starts before a child begins school and continues throughout the school years.[22]

Hyperbaric oxygen therapy Recent studies have demonstrated a dramatic improvement in CP symptomology when hyperbaric oxygen therapy is used as a treatment. Researchers in Brazil found a significant alleviation in symptomology and other characteristics in a study involving 218 cerebral palsy patients. Significant enhancements were documented showing improved vision, hearing and speech as well as a reduction of spasticity by 50%, which occurred in 94% of study patients.[23]

Nutritional counseling may help when dietary needs are not met because of problems with eating certain foods.

Both massage therapy[24] and hatha yoga[citation needed] are designed to help relax tense muscles, strengthen muscles, and keep joints flexible. Hatha yoga breathing exercises are sometimes used to try to prevent lung infections. More research is needed to determine the health benefits of these therapies for people with CP.

Surgery for people with CP usually involves one or a combination of:

  • Loosening tight muscles and releasing fixed joints, most often performed on the hips, knees, hamstrings, and ankles. In rare cases, this surgery may be used for people with stiffness of their elbows, wrists, hands, and fingers.
  • Straightening abnormal twists of the leg bones, i.e. femur (termed femoral anteversion or antetorsion) and tibia (tibial torsion). This is a secondary complication caused by the spastic muscles generating abnormal forces on the bones, and often results in intoeing (pigeon-toed gait). The surgery is called derotation osteotomy, in which the bone is broken (cut) and then set in the correct alignment.[25]
  • Cutting nerves on the limbs most affected by movements and spasms. This procedure, called a rhizotomy, "rhizo" meaning root and "tomy" meaning "a cutting of" from the Greek suffix 'tomia' reduces spasms and allows more flexibility and control of the affected limbs and joints.[26]
  • Botulinum Toxin A (Botox) injections into muscles that are either spastic or have contractures, the aim being to relieve the disability and pain produced by the inappropriately contracting muscle.[27]

Another way is that a new study has found that cooling the bodies and blood of high-risk full-term babies shortly after birth may significantly reduce disability or death.[28]

Conductive education (CE) was developed in Hungary from 1945 based on the work of Andras Peto. It is a unified system of rehabilitation for people with neurological disorders including cerebral palsy, Parkinson's disease and multiple sclerosis, amongst other conditions. It is theorized to improve mobility, self-esteem, stamina and independence as well as daily living skills and social skills. The conductor is the professional who delivers CE in partnership with parents and children. Skills learned during CE should be applied to everyday life and can help to develop age-appropriate cognitive, social and emotional skills. It is available at specialised centres.

Biofeedback is an alternative therapy in which people with CP learn how to control their affected muscles. Some people learn ways to reduce muscle tension with this technique. Biofeedback does not help everyone with CP.

Medical Therapy

Surgery

Prevention

Cultural references

  • (2002) The South Korean film Oasis follows the unconventional romance between two social outcasts, a marginalized ex-con and a young woman with CP.
  • (2004) The film Inside I'm Dancing focuses on a quadriplegic youth in Dublin who befriends someone with CP and acts as his translator.
  • (2005) In the Ricky Gervais and Stephen Merchant sitcom "Extras", a series one episode featured main protagonist Andy Millman ridiculing a female extra with CP (by mistaking her as a drunk); after the character (played by Francesca_Martinez) corrects him, he empathizes with her.

Notable cases

See also

External links

References

  1. "Cerebral Palsy." (National Center on Birth Defects and Developmental Disabilities, October 3, 2002), www.cdc.gov
  2. "Summary of "The Epidemiology of cerebral palsy: incidence, impairments and risk factors"". United Cerebral Palsy Research and Education Foundation (U.S.). Unknown parameter |accessdaymonth= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help)
  3. "Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003". MMWR Morb. Mortal. Wkly. Rep. 53 (3): 57–9. 2004. PMID 14749614. Retrieved 2007-08-12.
  4. "United Cerebral Palsy Research and Educational Foundation". Retrieved 2007-07-29.
  5. Bax M, Goldstein M, Rosenbaum P; et al. (2005). "Proposed definition and classification of cerebral palsy, April 2005". Developmental medicine and child neurology. 47 (8): 571–6. PMID 16108461.
  6. "Cerebral Palsy - Facts & Figures: History". United Cerebral Palsy Research and Education Foundation (U.S.). Retrieved 2007-07-06.
  7. "Cerebral Palsy: Hope Through Research". National Institute of Neurological Disorders and Stroke (U.S.). NIH Publication No. 06-159. 2006. Retrieved 2007-07-06. Unknown parameter |month= ignored (help)
  8. "Cerebral Palsy: a Guide for Care". Retrieved 2007-07-29.
  9. 9.0 9.1 "A very telling tale". Retrieved 2007-07-29. Text " SocietyGuardian.co.uk " ignored (help); Text " Society " ignored (help)
  10. "Language Log: A brief history of "spaz"". Retrieved 2007-07-29.
  11. "Infection in the Newborn as a Cause of Cerebral Palsy, 12/2004". United Cerebral Palsy Research and Education Foundation (U.S.). Retrieved 2007-07-05.
  12. "Thames Valley Children's Centre - Cerebral Palsy - Causes and Prevalence". Retrieved 2007-06-11.
  13. Johnson, Ann (2002). "Prevalence and characteristics of children with cerebral palsy in Europe". Developmental medicine and child neurology. 44 (9): 633–40. PMID 12227618.
  14. United Cerebral Palsy Research and Education Foundation (U.S.). "Cerebral Palsy Fact Sheet" (PDF). Unknown parameter |accessdaymonth= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help)
  15. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007). "How common are the "common" neurologic disorders?". Neurology. 68 (5): 326–37. doi:10.1212/01.wnl.0000252807.38124.a3. PMID 17261678.
  16. Johnson, Ann (2002). "Prevalence and characteristics of children with cerebral palsy in Europe". Developmental medicine and child neurology. 44 (9): 633–40. PMID 12227618.
  17. Thorngren-Jerneck K, Herbst A (2006). "Perinatal factors associated with cerebral palsy in children born in Sweden". Obstetrics and gynecology. 108 (6): 1499–505. doi:10.1097/01.AOG.0000247174.27979.6b. PMID 17138786.
  18. Hansen, Ruth A.; Atchison, Ben (2000). Conditions in occupational therapy: effect on occupational performance. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-683-30417-8.
  19. Crepeau, Elizabeth Blesedell; Willard, Helen S.; Spackman, Clare S.; Neistadt, Maureen E. (1998). Willard and Spackman's occupational therapy. Philadelphia: Lippincott-Raven Publishers. ISBN 0-397-55192-4.
  20. Balaban B, Yasar E, Dal U, Yazicioglu K, Mohur H, Kalyon TA (2007). "The effect of hinged ankle-foot orthosis on gait and energy expenditure in spastic hemiplegic cerebral palsy". Disability and rehabilitation. 29 (2): 139–44. PMID 17373095. |access-date= requires |url= (help)
  21. White H, Jenkins J, Neace WP, Tylkowski C, Walker J (2002). "Clinically prescribed orthoses demonstrate an increase in velocity of gait in children with cerebral palsy: a retrospective study". Developmental medicine and child neurology. 44 (4): 227–32. PMID 11995890. |access-date= requires |url= (help)
  22. Pennington L, Goldbart J, Marshall J (2004). "Speech and language therapy to improve the communication skills of children with cerebral palsy". Cochrane database of systematic reviews (Online) (2): CD003466. doi:10.1002/14651858.CD003466.pub2. PMID 15106204.
  23. "HBO Treatment.com". Retrieved 2007-09-03.
  24. Macgregor R, Campbell R, Gladden MH, Tennant N, Young D (2007). "Effects of massage on the mechanical behaviour of muscles in adolescents with spastic diplegia: a pilot study". Developmental medicine and child neurology. 49 (3): 187–91. doi:10.1111/j.1469-8749.2007.00187.x. PMID 17355474.
  25. Schejbalová A (2006). "[Derotational subtrochanteric osteotomy of the femur in celebral palsy patients]". Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca (in Czech). 73 (5): 334–9. PMID 17140515.
  26. Farmer JP, Sabbagh AJ (2007). "Selective dorsal rhizotomies in the treatment of spasticity related to cerebral palsy". doi:10.1007/s00381-007-0398-2. PMID 17643249.
  27. Hawamdeh ZM, Ibrahim AI, Al-Qudah AA (2007). "Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy". PMID 17268388.
  28. Shankaran S, Laptook AR, Ehrenkranz RA; et al. (2005). "Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy". N. Engl. J. Med. 353 (15): 1574–84. doi:10.1056/NEJMcps050929. PMID 16221780.
  29. Perens, Bruce (1996). "My use of "brain-damage" as a metaphor". Mailing list archive of debian-user. Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Unknown parameter |accessmonthday= ignored (help)
  30. "The Sheila Variations: August 2, 1776: "My hand trembles, but my heart does not"". Retrieved 2007-07-29.
  31. "About Marie Killilea". Retrieved 2007-07-29.
  32. Pearce JM (2000). "The emperor with the shaking head". Journal of the Royal Society of Medicine. 93 (6): 335–6. PMID 10911840.

Template:Cerebral palsy and other paralytic syndromes

ar:شلل دماغي de:Infantile Zerebralparese ko:뇌성마비 hr:Cerebralna paraliza id:Cerebral palsy he:שיתוק מוחין nl:Hersenverlamming no:Cerebral parese sr:Церебрална парализа fi:CP-vamma sv:Cerebral pares

Template:WS Template:WH

References